Live from the NIH registry
Studies recruiting near Surprise right now
Top 25 of 1,001 recruiting studies, sorted by proximity — each links to its official registry page
Cephea Early Feasibility Study
Mitral Regurgitation
N/A
Interventional 90 participants sought
Banner-University Medical Center Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Abbott Medical Devices
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Phoenix Childrens Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
KRAS G12C Mutation, KRAS G12S Mutation
Phase 1
Interventional 140 participants sought
Mayo Clinic, Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Kumquat Biosciences Inc.
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
City of Hope - Phoenix — Goodyear, Arizona (17.8 mi)
· Sponsor: Hoffmann-La Roche
An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures
Focal Onset Seizure, Primary Generalized Epilepsy
Phase 2
Interventional 50 participants sought
Praxis Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: Praxis Precision Medicines
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer site in Phoenix, AZ — Phoenix, Arizona (27.1 mi)
· Sponsor: Mediar Therapeutics
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Research Solutions of Arizona — Litchfield Park, Arizona (14.1 mi)
· Sponsor: Janssen Research & Development, LLC
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS)
Phase 2
Interventional 40 participants sought
Medical Dermatology Specialists Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Incyte Corporation
A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
Sepsis, Acute Kidney Injury
Phase 2
Interventional 124 participants sought
Research Site — Phoenix, Arizona (27.1 mi)
· Sponsor: AstraZeneca
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Hypertension, Pulmonary, Lung Diseases, Interstitial
Phase 2
Interventional 25 participants sought
Phoenix — Phoenix, Arizona (27.1 mi)
· Sponsor: Tectonic Operating Company, Inc.
Evaluate the Safety and Clinical Activity of HH2853
FL Lymphoma, Epithelioid Sarcoma
Phase 1, Phase 2
Interventional 254 participants sought
Mayo Clinic — Phoenix, Arizona (27.1 mi)
· Sponsor: Haihe Biopharma Co., Ltd.
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
HonorHeath Scottsdale Osborn Medical Center — Phoenix, Arizona (27.1 mi)
· Sponsor: GT Medical Technologies, Inc.
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Parkinson Disease
N/A
Observational 4,500 participants sought
Banner Research Institute — Sun City, Arizona (11.9 mi)
· Sponsor: Michael J. Fox Foundation for Parkinson's Research
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Arizona Gynecology Consultants — Phoenix, Arizona (27.1 mi)
· Sponsor: Rejoni Inc.
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigator Site — Phoenix, Arizona (27.1 mi)
· Sponsor: Alkermes, Inc.
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Xenoscience — Phoenix, Arizona (27.1 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Banner Sun Health Research Institute - Cleo Roberts Center for Clinical Research — Sun City, Arizona (11.9 mi)
· Sponsor: Annovis Bio Inc.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Colorectal Cancer, Colorectal Cancer (CRC)
Phase 1
Interventional 80 participants sought
Mayo Clinic Arizona — Phoenix, Arizona (27.1 mi)
· Sponsor: Cartography Biosciences
Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Severe Tricuspid Regurgitation
N/A
Interventional 1,186 participants sought
Abrazo Arizona Heart Hospital — Phoenix, Arizona (27.1 mi)
· Sponsor: Medtronic Cardiovascular
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Valleywise Health Medical Center — Phoenix, Arizona (27.1 mi)
· Sponsor: Eli Lilly and Company
American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Diabetes Mellitus, Chronic Kidney Diseases
N/A
Observational 500 participants sought
NIDDK-Phoenix Epidemiology and Clinical Research — Phoenix, Arizona (27.1 mi)
· Sponsor: University of New Mexico
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non Small Cell Lung Cancer, c-MET
Phase 3
Interventional 768 participants sought
Mayo Clinic Arizona /ID# 255858 — Phoenix, Arizona (27.1 mi)
· Sponsor: AbbVie
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
Mayo Clinic Cancer Center ( Site 0034) — Phoenix, Arizona (27.1 mi)
· Sponsor: Merck Sharp & Dohme LLC
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer
Phase 3
Interventional 1,000 participants sought
Ironwood Physicians P.C. dba Ironwood Cancer and Research Centers — Goodyear, Arizona (17.8 mi)
· Sponsor: Pfizer